In September 2024, a new paper on the topic of NOD2 agonists entitled: Distinctive Immune Signatures Driven by Structural Alterations in Desmuramylpeptide NOD2 Agonists (https://pubs.acs.org/doi/10.1021/acs.jmedchem.4c01577) was published in Journal of Medicinal Chemistry by our very own Špela Janež as part of her ongoing PhD research.
Congrats, Špela!
